Product Information_Qidong Gaitianli

Real-world studies once again prove that Huaiqihuang Granules are effective in treating childhood asthma

On April 22, 2017, at the 26th National Academic Forum on Childhood Asthma and Allergy Diseases held in Beijing, Professor Liu Chuanhe, the main researcher from the Children's Hospital of the Capital Institute of Pediatrics, released the "Huaiqihuang Granules for the Treatment of Childhood Bronchial Asthma" The latest statistical analysis results of the effectiveness of real-world research.

2017

The Latest Research Achievements of Huaiqihuang Granule in Nephropathy

On April 14, 2017, the 2017 national continuing education project of the Kidney Disease Professional Committee of the Chinese Society of Integrated Traditional Chinese and Western Medicine-the precision medicine and the prevention and treatment of kidney disease with integrated Chinese and Western medicine, was successfully completed at the Venice Evergrande Hotel in Qidong, Jiangsu.

2017

The Launch Meeting of Clinical Research on Huaier Granule in the Treatment of Non-small Cell Lung Cancer Held in Ning

On the morning of April 2, 2017, a randomized, double-blind, placebo parallel-controlled, multi-center clinical trial of Huaier Granules for the prevention of recurrence and metastasis of stage II-Ш a non-small cell lung cancer after adjuvant chemotherapy and the simultaneous registration of patients without adjuvant chemotherapy after surgery The start-up study was successfully held in Shangri-La Hotel, Nanjing.

2017

Qidong Gaitianli Pharmaceutical Co., Ltd. Annual Output of 0.12 billion Packages of Huaier Granules and Huaiqihuang Granules Production Technology Transformation and Second Publicity of Environmental Impact Assessment of GMP Workshop Expansion Project

The GMP project of the granule workshop of Qidong Gaitianli Pharmaceutical Co., Ltd. was approved by Qidong Environmental Protection Bureau in August 2002 and passed the environmental protection completion acceptance in May 2007. The expansion project of the production workshop of Qidong Gaitianli Pharmaceutical Co., Ltd. was approved by Qidong Environmental Protection Bureau in September 2009 and passed the environmental protection completion acceptance in September 2013.

2017

About Huaier Granules Drug Packaging Change Instructions

In view of the fact that many customers have consulted about the packaging of Huaier granules recently, the packaging of Huaier granules is now explained as follows: the original patent number [patent number] ZL 96116920.6 [international patent main classification] A61K35/70 on the small packaging box of Huaier granules has expired and is now changed to [patent number] ZL 20110034524.9. starting from December 1, FM012016, how to query the flow direction of Huaier granules can be passed by the 20 drug electronic supervision codes on the drug packaging box: one. Telephone enquiry: 95001111 2. SMS query: 1066950011

2017

The Mid-term Meeting of the Real World Study on the Treatment of Bronchial Asthma in Children by Huaiqihuang was Held in Ning

The mid-term meeting of the real-world study on the effectiveness of Huaiqihuang granules in the treatment of bronchial asthma in children was successfully held. 3000 cases were enrolled in the "real-world study on the effectiveness of Huaiqihuang granules in the treatment of bronchial asthma in children" sponsored by our company. The aim was to evaluate the effectiveness of Huaiqihuang granules in the treatment of asthma in children through multi-center and large-sample clinical observation, and to provide data support for further improving the clinical medication of Huaiqihuang granules.

2016

Huaier granule multi-center large sample liver cancer research results grand release!

On December 2, 2016, the seventh academic seminar of the China Branch of the International Hepatobiliary and Pancreatic Association and the second academic thought seminar of Qiu Fazu opened in Wuhan International Conference Center.

2016

Huaiqihuang Granules in the Treatment of Children with Bronchial Asthma Real World Study Officially Launched

On November 7, 2015, the real-world research on the treatment of bronchial asthma in children with Huaiqihuang Granules was held at Shangri-La Hotel, Nanchang. It is jointly organized by the main research unit Beijing Capital Institute of Pediatrics, the bidding unit Qidong Gaitianli Pharmaceutical Co., Ltd., the contract research organization Beijing Qihuang Drug Clinical Research Center and the data management and statistics unit Haiborui (Beijing) Data Technology Co., Ltd., a total of 22 clinical research units across the country participated in the meeting.

2015

< 1 2 3 4 5 >

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Address

1166 West Nanyuan Road, Qidong Economic Development Zone, Jiangsu Province

Telephone

0086-513-83101860 / 0086-513-83321533

E-mail

yonghu@gaitianli.com.cn

Mobile website

Public Number

Business License